Cargando…
Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model
Doxorubicin is employed alone or in combination for the treatment of several hematological and solid malignancies; despite its efficacy, there are associated cardiotoxicity limits both in its application in patients with heart disease risk factors and also in its long-term use. HFt-MP-PAS40 is a gen...
Autores principales: | Damiani, Verena, Falvo, Elisabetta, Fracasso, Giulio, Federici, Luca, Pitea, Martina, De Laurenzi, Vincenzo, Sala, Gianluca, Ceci, Pierpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536043/ https://www.ncbi.nlm.nih.gov/pubmed/28718812 http://dx.doi.org/10.3390/ijms18071555 |
Ejemplares similares
-
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy
por: Falvo, Elisabetta, et al.
Publicado: (2020) -
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors
por: Falvo, Elisabetta, et al.
Publicado: (2021) -
Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model
por: Conti, Giamaica, et al.
Publicado: (2021) -
Cryo-EM structure of the human ferritin–transferrin receptor 1 complex
por: Montemiglio, Linda Celeste, et al.
Publicado: (2019) -
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers
por: Fracasso, Giulio, et al.
Publicado: (2023)